Neoadjuvant Therapy of Colorectal Liver Metastases: Lessons Learned from Clinical Trials

被引：14

作者：

Brouquet, Antoine ^{[1
]}

Nordlinger, Bernard ^{[1
]}

机构：

[1] Univ Versailles St Quentin Yvelines, Hop Ambroise Pare, AP HP, Dept Digest & Oncol Surg, Versailles, France

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2010年 / 102卷 / 08期

关键词：

colorectal cancer; liver metastases; chemotherapy; OXALIPLATIN-BASED CHEMOTHERAPY; MULTICENTER RANDOMIZED-TRIAL; HEPATIC ARTERIAL INFUSION; LONG-TERM SURVIVAL; PHASE-III TRIAL; PREOPERATIVE CHEMOTHERAPY; SURGICAL RESECTION; 1ST-LINE TREATMENT; PATHOLOGICAL RESPONSE; FOLINIC ACID;

D O I：

10.1002/jso.21657

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Neoadjuvant chemotherapy is increasingly used to improve outcome in patients with colorectal liver metastases (CLM). In patients with unresectable CLM, recent clinical trials evaluate the ability of chemotherapy to increase the resectability rate. In patients with resectable CLM, the objective is to decrease the risk of recurrence after hepatectomy that still remains elevated despite the improvement of the surgical technique. A multidisciplinary approach of patients with CLM is desirable whatever the initial status of resectability. J. Surg. Oncol. 2010; 102: 932-936. (C) 2010 Wiley-Liss, Inc.

引用

页码：932 / 936

页数：5

共 50 条

[31] Colorectal Cancer Liver Metastases: Multimodal Therapy
Aykut, Berk
Lidsky, Michael E.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (01) : 119 - 141
[32] Pre-operative chemotherapy for colorectal cancer liver metastases: an update of recent clinical trials
Nasti, G.
Ottaiano, A.
Berretta, M.
Delrio, P.
Izzo, F.
Cassata, A.
Romano, C.
Facchini, G.
Scala, D.
Mastro, A.
Romano, G.
Perri, F.
Iaffaioli, R. V.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 209 - 218
[33] Systemic treatment of liver metastases from colorectal cancer
Stein, Alexander
Schmoll, Hans-Joachim
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2013, 5 (03) : 193 - 203
[34] Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases
Pietrantonio, Filippo
Mazzaferro, Vincenzo
Miceli, Rosalba
Cotsoglou, Christian
Melotti, Flavia
Fanetti, Giuseppe
Perrone, Federica
Biondani, Pamela
Muscara, Cecilia
Di Bartolomeo, Maria
Coppa, Jorgelina
Maggi, Claudia
Milione, Massimo
Tamborini, Elena
de Braud, Filippo
MEDICAL ONCOLOGY, 2015, 32 (07) : 1 - 10
[35] Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False
Desjardin, Marie
Bonhomme, Benjamin
Le Bail, Brigitte
Evrard, Serge
Brouste, Veronique
Desolneux, Gregoire
Fonck, Marianne
Becouarn, Yves
Bechade, Dominique
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2019, 13
[36] Neoadjuvant chemotherapy for colorectal liver metastases
Folprecht G.
Köhne C.-H.
Der Onkologe, 2006, 12 (6): : 571 - 582
[37] Prognostic factors after resection of colorectal liver metastases: from morphology to biology
Ribero, Dario
Vigano, Luca
Amisano, Marco
Capussotti, Lorenzo
FUTURE ONCOLOGY, 2013, 9 (01) : 45 - 57
[38] Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?
Dueland, Svein
Guren, Tormod K.
Hagness, Morten
Glimelius, Bengt
Line, Pal-Dag
Pfeiffer, Per
Foss, Aksel
Tveit, Kjell M.
ANNALS OF SURGERY, 2015, 261 (05) : 956 - 960
[39] Liver metastases from colorectal cancer
Cascinu, S
Catalano, V
Scartozzi, M
Baldelli, AM
Cellerino, R
ANNALS OF ONCOLOGY, 1997, 8 (04) : 393 - 399
[40] Lessons Learned from Radiation Oncology Clinical Trials
Liu, Fei-Fei
Okunieff, Paul
Bernhard, Eric J.
Stone, Helen B.
Yoo, Stephen
Coleman, C. Norman
Vikram, Bhadrasain
Brown, Martin
Buatti, John
Guha, Chandan
CLINICAL CANCER RESEARCH, 2013, 19 (22) : 6089 - 6100

← 1 2 3 4 5 →